# EDGAR Filing Document

**Accession Number:** 0001704287
**File Stem:** 0001213900-25-114602
**Filing Date:** 2025-11
**Character Count:** 2546
**Document Hash:** 5113a510d9d73d804f75735f780212ba
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-114602.hdr.sgml**: 20260407

**ACCESSION NUMBER**: 0001213900-25-114602

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251125

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bluejay Diagnostics, Inc.
- **CENTRAL INDEX KEY:** 0001704287
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 473552922
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 360 MASSACHUSETTS AVENUE, SUITE 203
- **CITY:** ACTON
- **STATE:** MA
- **ZIP:** 01720
- **BUSINESS PHONE:** (978) 631-0152

**MAIL ADDRESS:**
- **STREET 1:** 360 MASSACHUSETTS AVENUE, SUITE 203
- **CITY:** ACTON
- **STATE:** MA
- **ZIP:** 01720

**Bluejay Diagnostics, Inc.**

**360 Massachusetts Avenue, Suite 203**

**Acton, MA 01720**

November 25, 2025

***VIA EDGAR***

Securities and Exchange Commission<br> Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Bluejay Diagnostics, Inc.** |
|  | **Registration Statement on Form S-3** |
|  | **File No. 333-291042** |
|  | **Request for Acceleration of Effectiveness** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Bluejay Diagnostics, Inc. (the "<u>Company</u>") hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the "<u>Registration Statement</u>"), and declare the Registration Statement effective as of 4:30 p.m., Eastern Time, on November 26, 2025, or as soon thereafter as is practicable, or at such other time as the Company may orally request by telephone. The Company hereby authorizes each of Brian O'Fahey and Helen Ferrall of Hogan Lovells US LLP, counsel to the Company, to make such request on its behalf.

Please feel free to direct any questions or comments concerning this request to Mr. O'Fahey at (202) 637-6541 or Ms. Ferrall at (202) 804-7696, and once the Registration Statement has been declared effective, please notify Mr. O'Fahey or Ms. Ferrall by calling either of them at the same phone number.

---

| |
|:---|
| Very truly yours, |
| Bluejay Diagnostics, Inc. |
| /s/ Neil Dey |
| By: Neil Dey<br>Title: President and Chief Executive Officer |

---